Thousand Oaks, CA-August 5, 2009 Integrated Clinical Solutions (Inclinical) a developer of collaborative clinical operations software for the pharmaceutical, biotechnology and medical device industries, has partnered with Terrosa Technologies (Terrosa) to be its exclusive worldwide sales and distribution agent.
Inclinical and Terrosa have teamed up to bring inclinicalperform, to the clinical trial industry using Software as a Service (SaaS) technology. Terrosa will have exclusive responsibility for the sales of inclinicalperform software as well as developing the go-to-market strategies and sales operations.
Inclinical's, inclinicalperform, provides a collaborative working environment for clinical operations teams comprised of Sponsors, CROs, Sites and other stakeholders. Inclinicalperform provides all the basic functionality of traditional Clinical Trial Management Systems (CTMS) and integrates those functions with collaborative document control and distribution, issue/query resolution and contact resource management. Inclinicalperform is designed to support Title 21 CFR, Part 11, FDA compliance and good Information security practices.
"We are pleased to partner with Integrated Clinical Solutions so that they may maintain their focus on further development of new process automations within inclinicalperform," said Kim Terry, President of Terrosa Technologies. Armerding also stated, "Terrosa's integrated services will allow us to stay focused on what we do best-automating the clinical operations process."
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.